Ryosuke Miura

Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial

M. Ando, M. Hayakawa, Yoshiaki Sato, 2022, BMJ Open.

Fetal growth restriction followed by early catch-up growth impairs pancreatic islet morphology in male rats

M. Tsuji, M. Hayakawa, Yoshiyuki Takahashi, 2023, Scientific Reports.

Altered offspring neurodevelopment in an L-NAME-induced preeclampsia rat model

M. Hayakawa, Atsuto Onoda, Yoshiaki Sato, 2023, Frontiers in pediatrics.

Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic–ischemic brain injury in neonatal rats

Atsuto Onoda, Yoshiaki Sato, M. Dezawa, 2023, Scientific Reports.